Does Provider Type Affect Bone Health Surveillance in Chronic Pancreatitis?
- PDF / 529,193 Bytes
- 5 Pages / 595.276 x 790.866 pts Page_size
- 89 Downloads / 198 Views
ORIGINAL ARTICLE
Does Provider Type Affect Bone Health Surveillance in Chronic Pancreatitis? Padmavathi Srivoleti1 · Allison L. Yang2 · David X. Jin1 · Peter A. Banks1 · Julia McNabb‑Baltar1 Received: 26 April 2020 / Accepted: 6 August 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020
Abstract Background Bone density screening (DEXA) and vitamin D serum assay (Vit-D) are recommended in chronic pancreatitis, but adherence by providers is unknown. Aims Assess DEXA/Vit-D testing according to provider type. Methods A retrospective cohort study of chronic pancreatitis patients followed in a tertiary hospital (August 2017–2018) was conducted. Provider type was primary care (PCP), gastroenterologist, and pancreas specialist. Chi-square test and multivariable analysis were conducted to assess the relation between provider type and DEXA/Vit-D testing. Subset analyses were performed among patients with fecal elastase
Data Loading...
